Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.

From the category archives: OBN News


RSSL Webinar: Nitrosamines Analysis - Better Understanding the Risk

On 3rd February, RSSL's Daniel Nicolau will be speaking at a complimentary webinar considering the challenges of method development for nitrosamine analysis and the risk nitrosamines can pose.

Read the rest of entry »

RSSL Launches Sterility Webinar Series

Hosted by Tim Sandle, RSSL’s complimentary sterility webinar series continues with three new sessions to guide you through the complexities around COVID-19 prevention measures, best practices for cleaning and sterility testing.

Read the rest of entry »

Taylor Wessing Webinar: 'Optimising exits for European technology companies'

In collaboration with Silverpeak, this session will provide practical guidelines and best practice for those seeking to sell or make a partial realisation in the current environment. You will hear real life stories from an entrepreneur's recent exit experience together with a viewpoint from the private equity industry. 

TaylorWessing, new OBN sponsors are offering this webinar on Thursday 17 September 2020, 0830 - 1000.  Click here to REGISTER.

Oxford Nanopore: Nanopore sequencing 101 - online seminar series is back!

The first in the series will be hosted by James Brayer — Associate Director, Market Development, Oxford Nanopore Technologies — on 8th September at 5pm (BST). Join James for an introduction to nanopore sequencing and be sure to bring your questions along for a Q&A which will follow the presentation.

Registration link

Quotient: The Role of Biopharmaceutics in Early Drug Development - Webinar 6th October

Overcoming challenges for small molecules - webinar Nominated candidates entering clinical development often have sub-optimal physicochemical, biopharmaceutic or DMPK properties for oral delivery. Development teams are challenged with how to understand the properties of new drug candidates, how to design the appropriate formulation strategy and how to move quickly and successfully into early phase clinical trials. Along the way, it is important to identify developability risks and take steps to mitigate these factors, balanced carefully against time and cost investments. This webinar discusses effective strategies being used by biotech and pharmaceutical companies to overcome biopharmaceutic challenges for small molecules in today’s drug development pipeline; and explores alternative approaches for accelerating your early development plan. Speakers: Dr Vanessa Zann, Senior Drug Development Consultant, Quotient Sciences Dr Shriram Pathak, Senior Research Fellow, Scientific ...

Read the rest of entry »

Cyprotex announce hosting of a series of webinars on the topic of drug transporters

Cyprotex, an Evotec company, are hosting a series of webinars on the topic of drug transporters with speakers from Novartis, Genentech and Cyprotex.

These will take place on each Wednesday in September.

Learn more and reserve your seat:

BDO's First Life Sciences Live Webinar - Resilience, funding and cash flow - Preparing for the future

Registration is now open for our first Life Sciences Live webinar on Thursday 16 July at 10.30am

Read the rest of entry »

James Cowper Kreston Webinar: Here and Now - a guide to the strangest return to work in history

A guide through these unfamiliar waters and for preparing your business for getting back to normal working arrangements.

Read the rest of entry »

RSSL Webinar: Best Practices in Environmental Monitoring - Reviewing your Process for Compliance

This webinar forms part of of complimentary RSSL series following the launch of RSSL's sterility testing service and will guide you through the complexities around sterile products manufacturing, control, testing and release.

Read the rest of entry »

Cryo-EM for Drug Discovery - Unlock structure-based drug design of challenging projects

Unlock structure-based drug design of challenging projects.

For many biological targets of interest to pharma such as membrane proteins, structural information is difficult to obtain. The large size, complexity, and/or flexibility of these targets make them unsuitable for traditional structure determination techniques such as crystallography. Without structural insights to inform your drug design, you potentially miss out on discovering more effective drug candidates.

Read the rest of entry »

Pages: Previous12NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.